Literature DB >> 8454284

A denaturing gradient gel electrophoresis assay for sensitive detection of p53 mutations.

J S Beck1, A E Kwitek, P H Cogen, A K Metzger, G M Duyk, V C Sheffield.   

Abstract

p53 is a tumor suppressor gene located on 17p, a region of the human genome frequently deleted in tumors. Mutation of the p53 gene is an important step leading to development of many forms of human cancer. To simplify the analysis of tumors for p53 point mutations, we describe a GC-clamped denaturing gradient gel assay for detecting single-base substitutions within highly conserved regions of the p53 gene. This assay allows for efficient screening of tumors for single-base substitutions within the p53 gene and can be used to facilitate sequence analysis of p53 point mutations.

Entities:  

Mesh:

Year:  1993        PMID: 8454284     DOI: 10.1007/bf00230217

Source DB:  PubMed          Journal:  Hum Genet        ISSN: 0340-6717            Impact factor:   4.132


  27 in total

1.  Rapid and sensitive detection of point mutations and DNA polymorphisms using the polymerase chain reaction.

Authors:  M Orita; Y Suzuki; T Sekiya; K Hayashi
Journal:  Genomics       Date:  1989-11       Impact factor: 5.736

2.  Detection of polymorphisms of human DNA by gel electrophoresis as single-strand conformation polymorphisms.

Authors:  M Orita; H Iwahana; H Kanazawa; K Hayashi; T Sekiya
Journal:  Proc Natl Acad Sci U S A       Date:  1989-04       Impact factor: 11.205

3.  p53 mutations in human lymphoid malignancies: association with Burkitt lymphoma and chronic lymphocytic leukemia.

Authors:  G Gaidano; P Ballerini; J Z Gong; G Inghirami; A Neri; E W Newcomb; I T Magrath; D M Knowles; R Dalla-Favera
Journal:  Proc Natl Acad Sci U S A       Date:  1991-06-15       Impact factor: 11.205

4.  Identification of a germ-line mutation in the p53 gene in a patient with an intracranial ependymoma.

Authors:  A K Metzger; V C Sheffield; G Duyk; L Daneshvar; M S Edwards; P H Cogen
Journal:  Proc Natl Acad Sci U S A       Date:  1991-09-01       Impact factor: 11.205

5.  Separation of random fragments of DNA according to properties of their sequences.

Authors:  S G Fischer; L S Lerman
Journal:  Proc Natl Acad Sci U S A       Date:  1980-08       Impact factor: 11.205

Review 6.  The p53 tumour suppressor gene.

Authors:  A J Levine; J Momand; C A Finlay
Journal:  Nature       Date:  1991-06-06       Impact factor: 49.962

7.  Mutations in the p53 gene occur in diverse human tumour types.

Authors:  J M Nigro; S J Baker; A C Preisinger; J M Jessup; R Hostetter; K Cleary; S H Bigner; N Davidson; S Baylin; P Devilee
Journal:  Nature       Date:  1989-12-07       Impact factor: 49.962

8.  Mechanisms of p53 loss in human sarcomas.

Authors:  L M Mulligan; G J Matlashewski; H J Scrable; W K Cavenee
Journal:  Proc Natl Acad Sci U S A       Date:  1990-08       Impact factor: 11.205

9.  Mutational hotspot in the p53 gene in human hepatocellular carcinomas.

Authors:  I C Hsu; R A Metcalf; T Sun; J A Welsh; N J Wang; C C Harris
Journal:  Nature       Date:  1991-04-04       Impact factor: 49.962

10.  Mutations in the p53 gene in myelodysplastic syndromes.

Authors:  P Jonveaux; P Fenaux; I Quiquandon; J M Pignon; J L Laï; M H Loucheux-Lefebvre; M Goossens; F Bauters; R Berger
Journal:  Oncogene       Date:  1991-12       Impact factor: 9.867

View more
  5 in total

1.  Normal erythrocyte membrane Gs alpha bioactivity in two unrelated patients with acrodysostosis.

Authors:  L C Wilson; M E Oude Luttikhuis; M Baraitser; H M Kingston; R C Trembath
Journal:  J Med Genet       Date:  1997-02       Impact factor: 6.318

2.  Differential apoptosis markers in human keloids and hypertrophic scars fibroblasts.

Authors:  Bruna De Felice; Corrado Garbi; Margherita Santoriello; Alessandra Santillo; Robert R Wilson
Journal:  Mol Cell Biochem       Date:  2009-02-18       Impact factor: 3.396

3.  MDM-2 oncoprotein overexpression, p53 gene mutation, and VEGF up-regulation in angiosarcomas.

Authors:  C Zietz; M Rössle; C Haas; A Sendelhofert; A Hirschmann; M Stürzl; U Löhrs
Journal:  Am J Pathol       Date:  1998-11       Impact factor: 4.307

4.  p53 mutation is a poor prognostic indicator for survival in patients with hepatocellular carcinoma undergoing surgical tumour ablation.

Authors:  K Honda; E Sbisà; A Tullo; P A Papeo; C Saccone; S Poole; M Pignatelli; R R Mitry; S Ding; A Isla; A Davies; N A Habib
Journal:  Br J Cancer       Date:  1998-03       Impact factor: 7.640

5.  Validation of Ion TorrentTM Inherited Disease Panel with the PGMTM Sequencing Platform for Rapid and Comprehensive Mutation Detection.

Authors:  Abeer E Mustafa; Tariq Faquih; Batoul Baz; Rana Kattan; Abdulelah Al-Issa; Asma I Tahir; Faiqa Imtiaz; Khushnooda Ramzan; Moeenaldeen Al-Sayed; Mohammed Alowain; Zuhair Al-Hassnan; Hamad Al-Zaidan; Mohamed Abouelhoda; Bashayer R Al-Mubarak; Nada A Al Tassan
Journal:  Genes (Basel)       Date:  2018-05-22       Impact factor: 4.096

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.